AGO Recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer: Update 2017 (2017) Thill M, Liedtke C, Solomayer EF, Mueller V, Janni W, Schmidt M Journal article Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer (2017) Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Hoffmann O, et al. Journal article Automated Semi-Quantitative Analysis of Breast MRI: Potential Imaging Biomarker for the Prediction of Tissue Response to Neoadjuvant Chemotherapy (2017) Dietzel M, Kaiser C, Pinker K, Wenkel E, Hammon M, Uder M, Baiti BB, et al. Journal article Neoadjuvant Treatment of Breast Cancer - Advances and Limitations (2016) Fasching P, Gaß P, Hein A Journal article The PI3K Pathway: Background and Treatment Approaches (2016) Lux MP, Fasching P, Schrauder MG, Hein A, Jud S, Rauh C, Beckmann M Journal article Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study (2016) Gaß P, Fasching P, Fehm T, De Waal J, Rezai M, Baier B, Baake G, et al. Journal article 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts (2015) Jackisch C, Harbeck N, Huober J, Von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, et al. Journal article Romancing the Boost - the Higher, the Better? (2015) Sedlmayer F, Sautter-Bihl ML, Sauer R Journal article Is symptom-oriented follow-up still up to date? (2013) Mundhenke C, Moebus V Journal article, Review article Significance of tyrosine kinase inhibitors in the treatment of metastatic breast cancer (2009) Mundhenke C, Strauss A, Schem C Journal article, Review article